Summary document for interim clinical considerations for use of COVID-19 Vaccines currently authorized in the United States

i

Summary document for interim clinical considerations for use of COVID-19 Vaccines currently authorized in the United States

Public Domain

12/02/2022
By Centers for Disease Control and Prevention (U.S.)

File Language:

English

Details

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)
Description:

12/02/2022 CS321571-W

summary-interim-clinical-considerations.pdf
Content Notes:

Pfizer -- Moderna -- Janssen -- Novavax.
Subjects:

Coronavirus Infections/prevention & Control COVID-19 Vaccines COVID-19/prevention & Control Pandemics Vaccination
Document Type:

Pamphlet (or booklet)
Name as Subject:

Johnson & Johnson’s Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine
Genre:

Fact Sheet
Place as Subject:

United States
Pages in Document:

5 numbered pages
Collection(s):

Stephen B. Thacker CDC Library
Main Document Checksum:

urn:sha256:8b12e90f623cea8e4c62b25d814ae5e5a72dfab7c6517f93e20efcc969c2214c
Download URL:

https://stacks.cdc.gov/view/cdc/122633/cdc_122633_DS1.pdf
File Type:

[PDF - 181.36 KB ]

File Language:

English

ON THIS PAGE

Details

CDC STACKS serves as an archival repository of CDC-published products including scientific findings, journal articles, guidelines, recommendations, or other public health information authored or co-authored by CDC or funded partners.

As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.